Migraine Migraine  Guidelines are fairly consistent in rating the anticonvulsants topiramate and divalproex/sodium valproate, and the beta blockers propranolol and metoprolol as having the highest level of evidence for first-line use for migraine prophylaxis in adults.  Propranolol and topiramate have the best evidence in children; however, evidence only supports short-term benefit as of 2020. The beta blocker timolol is also effective for migraine prevention and in reducing migraine attack frequency and severity.  While beta blockers are often used for first-line treatment, other antihypertensives also have a proven efficiency in migraine prevention, namely the calcium channel blocker verapamil and the angiotensin receptor blocker candesartan. Tentative evidence also supports the use of magnesium supplementation.  Increasing dietary intake may be better.  Recommendations regarding effectiveness varied for the anticonvulsants gabapentin and pregabalin Migraine Migraine